NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

異位性皮膚炎 (AD) :流行病學預測

Atopic Dermatitis (AD) -Epidemiology Forecast to 2028

出版商 DelveInsight Business Research LLP 商品編碼 565330
出版日期 按訂單生產 內容資訊 英文 50 Pages
商品交期: 2-10個工作天內
價格
異位性皮膚炎 (AD) :流行病學預測 Atopic Dermatitis (AD) -Epidemiology Forecast to 2028
出版日期: 按訂單生產內容資訊: 英文 50 Pages
簡介

本報告提供美國,EU5個國家 (德國,西班牙,義大利,法國,英國) 、日本的異位性皮膚炎 (AD) 治療藥市場相關調查分析,提供疾病概要,流行病學 (實際成果·預測) 相關的系統性資訊。

第1章 報告概要

第2章 異位性皮膚炎 (AD) 流行病學概要

  • 病患人口

第3章 疾病的背景和概要

  • 病因
  • 危險因素
  • 病理生理學
  • 異位性皮膚炎 (AD)

第4章 流行病學和患者人口

  • 疾病定義
  • 人口與預測參數
  • 人口的測量手法
  • 主要7個國家
  • 美國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 主要7個國家的重症度別
  • 主要7個國家 (兒童)的重症度別
  • 主要7個國家 (成人)的重症度別
  • 主要7個國家的發癢的程度
  • 中症∼重病的發癢的程度
  • 主要7個國家的未治療
  • 主要7個國家的未治療 (兒童·成人)

第5章 治療行為

第6章 治療流程

  • 治療目標
  • 治療指南 (美國)
  • 指南 (日本)
  • 治療的指南 (歐洲)

第7章 目前未滿足需求

第8章 附錄

第9章 調查手法

第10章 DelveInsight的功能

第11章 免責聲明

第12章 關於DelveInsight

目錄
Product Code: DIEI0256

DelveInsight's "Atopic Dermatitis (AD) - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Atopic Dermatitis (AD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Atopic Dermatitis (AD) Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Atopic Dermatitis (AD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Atopic Dermatitis (AD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Atopic Dermatitis (AD) scenario.

Atopic Dermatitis (AD) Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Atopic Dermatitis (AD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Atopic Dermatitis (AD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Atopic Dermatitis (AD) Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Atopic Dermatitis (AD)

Key assessments

  • Patient Segmentation in Atopic Dermatitis (AD)
  • Atopic Dermatitis (AD) Risk & Burden
  • Factors driving growth in a specific Atopic Dermatitis (AD) patient population

Table of Contents

1. Report Introduction

2. Atopic Dermatitis (AD) Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Atopic Dermatitis (AD) in 2016
  • 2.2. Patient Share Distribution of Atopic Dermatitis (AD) in 2028

3. Disease Background and Overview: Atopic Dermatitis (AD)

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Atopic Dermatitis (AD) in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Atopic Dermatitis (AD) in 7MM - By Countries

5. Epidemiology of Atopic Dermatitis (AD) by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
    • 5.1.3. Sub-Type Specific cases of the Atopic Dermatitis (AD) *
    • 5.1.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
    • 5.1.5. Diagnosed Cases of the Atopic Dermatitis (AD)
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
    • 5.4.3. Sub-Type Specific cases of the Atopic Dermatitis (AD)*
    • 5.4.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
    • 5.4.5. Diagnosed Cases of the Atopic Dermatitis (AD)
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
    • 5.5.3. Sub-Type Specific cases of the Atopic Dermatitis (AD)*
    • 5.5.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
    • 5.5.5. Diagnosed Cases of the Atopic Dermatitis (AD)
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
    • 5.6.3. Sub-Type Specific cases of the Atopic Dermatitis (AD)*
    • 5.6.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
    • 5.6.5. Diagnosed Cases of the Atopic Dermatitis (AD)
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
    • 5.7.3. Sub-Type Specific cases of the Atopic Dermatitis (AD)*
    • 5.7.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
    • 5.7.5. Diagnosed Cases of the Atopic Dermatitis (AD)
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
    • 5.8.3. Sub-Type Specific cases of the Atopic Dermatitis (AD)*
    • 5.8.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
    • 5.8.5. Diagnosed Cases of the Atopic Dermatitis (AD)
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
    • 5.9.3. Sub-Type Specific cases of the Atopic Dermatitis (AD)*
    • 5.9.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
    • 5.9.5. Diagnosed Cases of the Atopic Dermatitis (AD)

6. Unmet Needs of the Atopic Dermatitis (AD)

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Atopic Dermatitis (AD) in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Atopic Dermatitis (AD) in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Atopic Dermatitis (AD) in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Atopic Dermatitis (AD) in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Atopic Dermatitis (AD) in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Atopic Dermatitis (AD) in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Atopic Dermatitis (AD) in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Atopic Dermatitis (AD) in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Atopic Dermatitis (AD) in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Atopic Dermatitis (AD) in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Atopic Dermatitis (AD) in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Atopic Dermatitis (AD) in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Atopic Dermatitis (AD) in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Atopic Dermatitis (AD) in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Atopic Dermatitis (AD) in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Atopic Dermatitis (AD) in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Atopic Dermatitis (AD) in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Atopic Dermatitis (AD) in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Atopic Dermatitis (AD) in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Atopic Dermatitis (AD) in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Atopic Dermatitis (AD) in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Atopic Dermatitis (AD) in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Atopic Dermatitis (AD) in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Atopic Dermatitis (AD) in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Atopic Dermatitis (AD) in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Atopic Dermatitis (AD) in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Atopic Dermatitis (AD) in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Atopic Dermatitis (AD) in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Atopic Dermatitis (AD) in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Atopic Dermatitis (AD) in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Atopic Dermatitis (AD) in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Atopic Dermatitis (AD) in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Atopic Dermatitis (AD) in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Atopic Dermatitis (AD) in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Atopic Dermatitis (AD) in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Atopic Dermatitis (AD) in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Atopic Dermatitis (AD) in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Atopic Dermatitis (AD) in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Atopic Dermatitis (AD) in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Atopic Dermatitis (AD) in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Atopic Dermatitis (AD) in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Atopic Dermatitis (AD) in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Atopic Dermatitis (AD) in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Atopic Dermatitis (AD) in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Atopic Dermatitis (AD) in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Atopic Dermatitis (AD) in Japan (2016-2028)